The Role of Diet in Periodontal Inflammation: A Controlled Clinical Study
Periodontal Inflammation, Periodontal Diseases
About this trial
This is an interventional treatment trial for Periodontal Inflammation focused on measuring Experimental Gengivitis, Nutraceutical, Periodontal Inflammation
Eligibility Criteria
Inclusion Criteria: Optimal systemic health conditions Non-Smoking Absence of cardio-vascular pathologies Absence of pulmonary pathologies Non-diabetic Not pregnant FMPS <20% FMBS <20% Omnivorous or vegan/vegetarian diet for at least a year Absence of periodontitis Exclusion Criteria: Smokers Presence of systemic pathologies Presence of cardio-vascular disease Presence of periodontitis FMPS>20% FMBS>20% Pregnant women Presence of blood pathologies Taking medicines (hydantoins, nifedipine or cyclosporine) Taking oral contraceptives Bacterial, viral or fungal infections Idiopathic gingival fibromatosis Mucocutaneous disorders Allergic reactions to toothpastes and mouthwashes
Sites / Locations
- G. D'Annunzio UniversityRecruiting
Arms of the Study
Arm 1
Arm 2
Experimental
Active Comparator
Patients with a vegan/vegetarian diet
Patients with an omnivorous diet
After excluding patients with clinical signs of periodontitis, the patients recruited at baseline underwent prophylaxis and home oral hygiene instructions were given with brushing and flossing in order to reduce the parameters of inflammation and the presence of plaque (FMPS and FMBS). The use of antiseptics (chlorhexidine mouthwash 0.20%) was prescribed twice a day for 15 days. After 15 days from baseline (T0) all patients were recorded the parameters of FMPS, FMBS, PPD and Eastman Interdental Bleeding Index (EIBI) and were asked to stop using dental floss and mouthwash. All patients were recalled weekly 4 times after T0 (T1, T2, T3, T4) in order to monitor the parameters of inflammation and plaque accumulation by recording FMBS, FMPS and EIBI.
After excluding patients with clinical signs of periodontitis, the patients recruited at baseline underwent prophylaxis and home oral hygiene instructions were given with brushing and flossing in order to reduce the parameters of inflammation and the presence of plaque (FMPS and FMBS). The use of antiseptics (chlorhexidine mouthwash 0.20%) was prescribed twice a day for 15 days. After 15 days from baseline (T0) all patients were recorded the parameters of FMPS, FMBS, PPD and Eastman Interdental Bleeding Index (EIBI) and were asked to stop using dental floss and mouthwash. All patients were recalled weekly 4 times after T0 (T1, T2, T3, T4) in order to monitor the parameters of inflammation and plaque accumulation by recording FMBS, FMPS and EIBI.